---
$id: https://graph.org.ai/products/commodity/51101662
$type: Product
source: UNSPSC
code: "51101662"
title: "Halofuginone"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Halofuginone

**UNSPSC Code**: 51101662
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an angiogenesis activator inhibitor and alkaloid with the molecular formula C16H17BrClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L31MM1385E, chemically known as 4(3h)-quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans- but generally known as halofuginone, which bears US NIH Compound Identifier 62891. European Medicines Agency schedules Halofuginone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08000MIG. The term HALOFUGINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). HALOFUGINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halofuginone under HS 29335995 and SITC 51576. As of Q4 2014, HALOFUGINONE remains the US FDA Preferred Term for this commodity. Halofuginone bears US NLM identifiers UMLS ID C0062095 and NCI Concept Code C1120. SMILES: BRC1CC2NCN(CC(=O)CC3NCCCC3O)C(=O)C2CC1CL.

